All

MaaT Pharma Launches a Global Offering of approximately 18 Million Euros
14 May 2024

MaaT Pharma Launches a Global Offering of approximately 18 Million Euros

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

Read more
SumUp raises $1.5 billion in debt financing
1 May 2024

SumUp raises $1.5 billion in debt financing

In a major deal that reaffirms the market’s confidence in global fintech SumUp as a company with solid revenues and foundations, and a bright future, the company raised...

Read more